This track will explore the latest discoveries in tumor biology, focusing on the molecular mechanisms underlying cancer progression. Researchers are invited to present their findings on tumor microenvironment interactions and genetic alterations.

This session will highlight cutting-edge approaches in immunotherapy for cancer treatment, including novel immune checkpoint inhibitors and CAR-T cell therapies. Participants will discuss the challenges and successes of translating these therapies into clinical practice.

This track will delve into the role of precision medicine in tailoring cancer treatment to individual patient profiles. Presentations will cover genomic profiling, biomarker discovery, and the integration of personalized therapies in clinical settings.

This session will focus on effective cancer prevention strategies, including lifestyle modifications and public health initiatives. Researchers will share insights on the impact of early detection and screening programs in reducing cancer incidence.

This track will emphasize the importance of patient-centered care approaches in oncology practice. Discussions will include the integration of patient preferences, shared decision-making, and supportive care in cancer treatment plans.

This session will investigate the role of the tumor microenvironment in cancer metastasis and progression. Researchers will present their findings on cellular interactions, extracellular matrix components, and immune evasion mechanisms.

This track will cover the latest trends and breakthroughs in cancer research, including novel therapeutic targets and innovative research methodologies. Participants are encouraged to share their insights on future directions in oncology research.

This session will focus on health promotion strategies aimed at increasing cancer awareness and prevention. Presentations will explore community-based interventions and educational programs designed to reduce cancer risk.

This track will discuss the design and outcomes of clinical trials in oncology, highlighting novel therapeutics and treatment regimens. Researchers will share their experiences and insights into the challenges of conducting trials in diverse populations.

This session will explore integrative approaches to cancer care, combining conventional treatments with complementary therapies. Discussions will focus on the evidence base for integrative practices and their impact on patient outcomes.

This track will address the ethical challenges faced in oncology research, including informed consent, patient autonomy, and the use of placebo controls. Participants will engage in discussions on best practices for ethical conduct in cancer studies.